ATEC is no longer just a fast-growing spine company adding another technology box to its portfolio. With $764 million in revenue in 2025, up 25% year over year, it is increasingly behaving like a company trying to build procedural control around the areas where it already believes it has competitive leverage.
That is the real significance of Valence, ATEC’s robotic solution for spine surgery.
Valence has been positioned to extend ATEC’s advantage in the lateral approach, which is important because this suggests robotics is not being introduced as a standalone prestige asset. It is being deployed as a reinforcing technology within a strategy the company already understands well. In spine, that distinction matters. A robot without procedural alignment is just an expensive platform looking for a story. A robot tied to a defined surgical pathway is something else.
The system uses an intraoperative 3D scan and optical tracking to assist with pedicle screw placement and interbody device placement. On paper, that places Valence into the familiar robotics-and-navigation territory that many spine companies want exposure to. But in ATEC’s case, the more interesting question is not whether it now has a robotic platform. It is whether that platform can deepen adoption in the workflows where ATEC is already strongest.
The origins of the technology also matter. Valence came through ATEC’s $55 million acquisition in 2023 from Accelus, then associated with Integrity Implants & Fusion Robotics. At the time, the company said it expected the platform to begin generating revenue in 2025. That makes the current stage less of a surprise launch and more of a planned strategic step, one that fits into a broader effort to move beyond implants alone.
In that sense, Valence is not just about entering robotics. It is about using robotics to reinforce procedural identity. For ATEC, the opportunity is not merely to participate in the spine robotics segment, but to make the technology serve a surgical approach where it already sees room to lead.
About ATEC
ATEC, through its wholly owned subsidiaries, Alphatec Spine, Inc., EOS imaging S.A. and SafeOp Surgical, Inc., is a medical device company dedicated to revolutionizing the approach to spine surgery through clinical distinction. ATEC’s Organic Innovation Machine™ is focused on developing new approaches that integrate seamlessly with the Company’s expanding AlphaInformatiX Platform to better inform surgery and more safely and reproducibly achieve the goals of spine surgery. ATEC’s vision is to be the Standard Bearer in Spine. For more information, visit us at www.atecspine.com.